跳至主要内容
临床试验/DRKS00000788
DRKS00000788已完成2 期

Differential effect of Carbamazepine on cortical excitability in subjects with different genotypes for SCN1A as measured by transcranial magnetic stimulation (TMS) - EPICURE SP 5- TMS- SCN1A

Philipps-Universität Marburg0 个研究点目标入组 101 人开始时间: 2011年4月5日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
101

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Men and women age =18 years
  • Righthandedness as investigated by the Edinburgh handedness inventory (EHI =80)
  • Provided signed written informed consent
  • Cognitive and physical ability to understand the experimental procedure, to take the antiepileptic medication and to be investigated by TMS

排除标准

  • Progressive neurological disorder
  • Admission for a psychiatric disorder within the last 6 months, attempted suicide, psychosis or other severe psychiatric disorder
  • Severe disease of the liver, kidneys or heart
  • acute intermittend porphyria
  • Severe endocrinological disorder
  • Disturbances of the sodium levels
  • Pregnancy or lactation period
  • Epileptic or non-epileptic seizures
  • Chronic alcohol- or drug- abuse within the last two years
  • Allergic reaction to the medication tested
  • Intake of antiepileptic drugs or other drugs influencing cortical excitability
  • Metal implantates in head-neck-area
  • Other abnormal laboratory results, medical history or clinical findings that might be of disadvantage for the subject or the study
  • Inclusion in another clinical or neurophysiological study at the time of investigation

研究者

相似试验